03/21/18 9:55 PM
UNFINISHED BUSINESS - The Chair announced that the unfinished business was on the Speaker's approval of the Journal and put the question de novo.
03/21/18 9:55 PM
MOMENT OF SILENCE - The House observed a moment of silence for the service men who gave their lives in service of our Nation in a Navy jet crash off the coast of the Florida Keys during a training exercise.
03/21/18 9:54 PM H.R. 5247
Motion to reconsider laid on the table Agreed to without objection.
03/21/18 9:54 PM H.R. 5247
On passage Passed by recorded vote: (Roll no. 121).
03/21/18 9:54 PM H.R. 5247
On passage Passed by recorded vote: 267 - 149 (Roll no. 121).
03/21/18 9:44 PM H.R. 5247
On passage Roll Call 121 - Recorded vote pending.
03/21/18 9:44 PM H.R. 5247
On motion to recommit with instructions Failed by the Yeas and Nays: (Roll no. 120).
03/21/18 9:44 PM H.R. 5247
On motion to recommit with instructions Failed by the Yeas and Nays: 182 - 233 (Roll no. 120).
03/21/18 9:16 PM H.R. 5247
On motion to recommit with instructions Roll Call 120 - Yea and Nay vote pending.
03/21/18 9:16 PM H.R. 5247
Considered as unfinished business. H.R. 5247 — "To authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes."
